The Latest Breaking News from Medicine

Veru Inc. (VERU) stock has exhibited solid momentum over the past few weeks owing to the company’s recent clinical study of oral medicine sabizabulin, which reduces fatalities by more than 50% in severe COVID-19 patients. However, given Veru’s declining revenue and poor profitability, can the stock sustain its price rally?…

Modern drug discovery is an expensive and complicated process. Hundreds of scientists and at least a decade are often required to produce a single medicine. One of the most critical steps in this process is the first one – identifying new chemical compounds that could be developed into new medicines.

AstraZeneca plc (NASDAQ:AZN) shared detailed results from the PROVENT Phase 3 pre-exposure prophylaxis (prevention) trial of Evusheld (tixagevimab and cilgavimab), formerly AZD7442. The data showed that Evusheld reduced the risk of developing symptomatic COVID-19 by 77% in the primary analysis and 83% in the six-month follow-up analysis, compared to placebo.  There were no…

Codiak BioSciences Inc (NASDAQ:CDAK) announced new preclinical data from its pan beta-coronavirus vaccine program.  The data demonstrate the potential for the vaccine candidate to induce cross-neutralizing antibody protection against multiple strains and an antigen-specific & immune response against structurally conserved regions of various coronavirus variants. Preclinical data showed a durable antibody response lasting…

Zipline, an American company that specializes in using autonomously flying drones to deliver medical supplies, has taken off in Japan

Socrates Rosenfeld, CEO and co-founder of Jane Technologies In the last week of August, the remaining U.S. troops flew out of Afghanistan ending two decades of war. Over that period of time, between 1.9 to 3 million U.S. service members served in Afghanistan and Iraq, with over half of them…